Actaea heracleifolia
Actaea heracleifolia · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Actaea heracleifolia is a medicinal plant known for its potent bioactive properties derived primarily from its rhizome. Research indicates that its extracts and decoctions possess significant antiosteoporotic and antiviral activities. These therapeutic effects are largely attributed to key chemical constituents such as Cimicifugic acid A, Cimicifugic acid J, and Fukinolic acid. Due to these characteristics, the plant is studied as a potential natural intervention for managing conditions like osteoporosis. Consequently, both concentrated extracts and traditional preparations serve as important subjects in pharmacological studies.
- Synonyms
- Cimicifuga Heracleifolia
- Common names
- Not available
- Family
- Ranunculaceae
- Distribution
- Not available
- Plant Parts
- Rhizome
Classification
Common Names
Actaea heracleifolia is a plant recognized by a variety of diverse regional names across different languages. In Chinese-speaking regions, it is widely known as 大三叶升麻 or 大三叶升麻, and also referred to as da san ye sheng ma. Its nomenclature extends into Slavic contexts, where it is identified as Клопогон борщевиколистный. These various common names highlight the plant's widespread presence and its importance across different cultural landscapes. Understanding these linguistic relationships provides a clearer picture of how this species is categorized globally.
Sources: Catalogue of Life (COL)
Synonyms
Actaea heracleifolia is a distinctive botanical species that is often identified by its alternative scientific name. In many taxonomic records, you will find it listed under the synonym Cimicifuga heracleifolia. This nomenclatural overlap occurs because the plant has been reclassified within different genera over time. Understanding these related names is essential for gardeners and botanists seeking accurate identification. Consequently, recognizing both terms ensures clarity when researching the specific care requirements for this plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Actaea heracleifolia is a distinct biological entity belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It falls specifically into the order Ranunculales, which helps define its evolutionary lineage. Further narrowing its identity, the plant is a member of the family Ranunculaceae. Ultimately, this species is categorized under the genus Actaea, highlighting its unique botanical characteristics.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Ranunculaceae |
| Genus | Actaea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Actaea heracleifolia is a notable species primarily found throughout the temperate regions of Asia. Its distribution is heavily concentrated within China, spanning from the North-Central and South-Central provinces to the vast landscapes of Inner Mongolia and Manchuria. Beyond the Chinese borders, the plant also thrives across the Eastern Asian landscape, specifically within Korea. This wide geographic range highlights the plant's ability to adapt to diverse temperate environments across the continent. Understanding these specific regional patterns provides valuable insight into the natural habitat of this species.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Actaea heracleifolia is a self-supporting herb characterized by its distinct growth form. This species typically reaches a maximum height of only one meter. Its compact stature allows it to thrive within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Actaea heracleifolia has demonstrated significant therapeutic potential through its diverse biological activities. Research indicates that this plant possesses antiosteoporotic properties, specifically showing the ability to prevent bone loss in ovariectomized mice by preserving trabecular bone mass and density. Furthermore, the species exhibits notable antiviral activity, particularly against the enterovirus A71 which causes hand-foot-and-mouth disease. Studies have successfully identified specific compounds within the plant, such as fukinolic acid, that act as potent inhibitors of this viral infection. Together, these findings highlight the importance of Actaea heracleifolia in both bone health management and antiviral drug development.
Compounds
Actaea heracleifolia, also known as Cimicifuga heracleifolia, serves as a rich source of several biologically significant compounds. Research has identified that this plant contains fukinolic acid, which exhibits notable antiviral properties. Furthermore, the plant is characterized by the presence of specific chemical constituents known as cimicifugic acid A and cimicifugic acid J. These substances were isolated from the aqueous extract of the rhizome during studies focused on combating enterovirus A71. Together, these identified compounds highlight the medicinal potential inherent within the chemical profile of Actaea heracleifolia.
Conditions
Actaea heracleifolia demonstrates significant therapeutic potential by reducing IL-8 levels in response to influenza virus infections. The plant also effectively treats bone loss by preserving trabecular bone mass and density. In studies involving ovariectomized mice, Actaea heracleifolia successfully treats OVX-induced bone loss. Furthermore, it treats the OVX-induced increase in body weight observed in female mice. Finally, the administration of this plant treats elevated serum ALP levels by reducing their activity.
Preparations
Actaea heracleifolia is prepared as CH, an Asian species of Cimicifugae rhizome used to study bone loss in mice. This specific preparation, referred to as CH, has been shown to preserve trabecular bone mass and reduce serum alkaline phosphatase levels. Additionally, Actaea heracleifolia is prepared as an extract to investigate its anti-inflammatory properties. In experimental settings, the Cimicifuga heracleifolia extract is administered to mice to observe its effects on interleukin-8 production following influenza virus infections. Both the CH preparation and the plant extract serve as critical tools for exploring the medicinal potential of this species.
Parts used
Actaea heracleifolia, also known as Cimicifuga heracleifolia, contains a medicinal rhizome that has demonstrated significant therapeutic potential in various studies. Research indicates that aqueous extracts from this plant's rhizome possess potent antiviral activity, specifically against enterovirus A71. Scientists have identified active compounds within these extracts, such as fukinolic acid, which serve as key components in fighting viral infections. Furthermore, the rhizome has shown promise in bone health research, specifically regarding its ability to prevent bone loss in animal models. These findings highlight the diverse pharmacological importance of the plant's rhizome in addressing both viral and skeletal health concerns.